ECI830

(Synonyms: CDK2-IN-37)
Customer Review

Based on 1 Customer Validation

ECI830 (CDK2-IN-37) is an orally active, ATP-competitive and highly selective CDK2 inhibitor. ECI830 shows high selectivity over other CDK family members. ECI830 can be used for the study of HR+/HER2- breast cancer and CCNE1-amplified tumors (such as ovarian cancer and lung cancer).

For research use only. We do not sell to patients.

  • Purity: 98.01%
  • CAS No.: 3054692-62-2
  • Formula: C19H24N6O3
  • Molecular Weight:384.43
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00